Synthetic CBD as a Therapy for COVID-19

Synthetic CBD Oil Droplets as a Therapy for Mild to Moderate SARS-CoV-2 Infection. Assesment of Efficacy and Safety.

The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.

Inclusion Criteria:

• COVID 19 patients
• 18 Years and older

Exclusion Criteria:

• Respiratory failure requiring mechanical ventilation
• Intensive care unit admission
• Neutrophile con. < 1000 cells/mm3
• Lymphocyte con < 500 cells/mm3
• Liver enzymes 5 times higher then the norm
• QT interval longer then 500 ms.
• Pregnancy
• Hemodialysis renal replacement therapy
• Active or prior psychotic event